June 2010- Volume 6, Issue 6
June 2010
In this Issue
Research & Development
Biotech expertise to raise profile of neglected disease
Biotech expertise to raise profile of neglected disease
Medicines for Malaria Venture and Anacor Pharmaceuticals collaborate on applying boron chemistry technology to treat malaria
Combining immunomodulators with cancer vaccines
Combining immunomodulators with cancer vaccines
IRX Therapeutics announces cancer vaccine collaboration with Japan’s National Cancer Research Center
The better to see you with
The better to see you with
EyeGate, GSK collaborate on ocular delivery of drugs
TNT for tumors
TNT for tumors
Peregrine grants Stason rights to develop TNT products in APEC countries
No gain without pain
No gain without pain
sanofi-aventis, Glenmark sign global agreement aimed at treating chronic pain
Commentary
Preanalytical sample handling protocols can advance personalized medicine and science
Preanalytical sample handling protocols can advance personalized medicine and science
Basic research and industry adoption of standard protocols and tools for preanalytical sample handling are necessary to advance personalized medicine and science
What is ‘personalized medicine?’
What is ‘personalized medicine?’
Medicine remains an art to be practiced. Given that no two doctors and no two patients are the same in all respects, it has always been personalized
Editor's Focus
We are all witnesses … to failure and success
We are all witnesses … to failure and success
We must make better use of our time, energy and priorities, focusing not on negative outcomes, but asking the questions that will lead us to results we seek.
Instruments & Informatics
Back in the workflow
Back in the workflow
Freeslate announces software partnership with Johnson & Johnson Pharmaceutical Research & Development
Meeting mass spec challenges head-on
Meeting mass spec challenges head-on
Samuel Lunenfeld Research Institute advances protein research with help from new AB SCIEX technology
Arrayed from end to end
Arrayed from end to end
BioDiscovery and Exiqon sign OEM agreement to provide complete miRNA analysis solution
Temperature- controlled Sample Storage
Temperature- controlled Sample Storage
BioStorage will use Biomatrica’s RT storage technology to provide conversion services
Omics & Systems Biology
Going with the flow
Going with the flow
Thermo Fisher Scientific acquires Proxeon, a proteomics workflow solution provider
Two are better than one
Two are better than one
Duke, LabCorp combine forces to create The Biomarker Factory
HTG signs collaboration agreement with John Wayne Cancer Institute
HTG signs collaboration agreement with John Wayne Cancer Institute
Aim is to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using classical surgical pathology samples
Going boldly into the transcriptome
Going boldly into the transcriptome
Ocimum partners with Jivan to provide sequencing-based transcriptome profiling services
Special Reports
CROs take advantage of M&A madness
CROs take advantage of M&A madness
The landscape has been changing drastically over the last year or so, with a string of mergers and acquisitions resulting in the formation of new collaborations, new companies and allegiances that have reshaped the market
Where are the jobs?
Where are the jobs?
With companies cutting staff and outsourcing services, your job may be moving overseas; but then again, it may just be moving down the street
Global News
Striking from two sides … or more
Striking from two sides … or more
TB Alliance and AstraZeneca form research collaboration to fight tuberculosis
A breath of fresh air
A breath of fresh air
Novartis acquires Oriel Therapeutics, gains portfolio of respiratory products targeting asthma and COPD
Sticking together against Huntington’s
Sticking together against Huntington’s
BioFocus and CHDI enter new five-year collaboration for Huntington’s disease therapeutics
Scientists working for scientists
Scientists working for scientists
Stemgent and Miltenyi Biotec agree to co-develop stem cell research products
Taking a BiTE out of multiple myeloma
Taking a BiTE out of multiple myeloma
Boehringer Ingelheim, Micromet announce global collaboration for multiple myeloma BiTE antibody
Eppendorf and Akonni to co-market extraction kits
Eppendorf and Akonni to co-market extraction kits
Eppendorf North America and Akonni Biosystems have entered into a joint marketing agreement to promote Akonni TruTip nucleic acid extraction kits configured for use with Eppendorf epMotion automated pipetting systems.
Contract Services
From molecule to market
From molecule to market
Charles River Laboratories acquires WuXi PharmaTech for $1.6 billion, creating a CRO with services from early-stage drug development to clinical trials
Doxorubicin’s new clothes
Doxorubicin’s new clothes
SIOGEN and Veeda announce partnership to develop new nanoparticle formulation of Doxorubicin for cancer treatment
Expressing themselves
Expressing themselves
Aragen and CEVEC sign agreement covering novel human expression system
Fordham builds partnership for global healthcare innovation
Fordham builds partnership for global healthcare innovation
ACRO funds Global Healthcare Innovation Management Center At Fordham University Schools of Business
A New York state of MSA
A New York state of MSA
Agreement enables CLINiLABS to add ECG core lab services
DSM Biologics launches Australian biopharma manufacturing facility
DSM Biologics launches Australian biopharma manufacturing facility
DSM Biologics, a business unit of DSM Pharmaceutical Products, a global business providing cGMP custom manufacturing services across all facets of the pharmaceutical industry, has signed preliminary agreements with the Australian government to design, build and operate the first major Australia-based mammalian biopharmaceutical manufacturing facility, which will be located in Brisbane.
Diagnostics
On the right path for MDx growth
On the right path for MDx growth
ExonHit acquires RedPath Integrated Pathology to create ‘molecular diagnostic powerhouse’
Promising diagnosis for success
Promising diagnosis for success
As part of a strategic agreement, bioMérieux purchases $5 million equity stake in Knome
Clavis and Clovis take a companion
Clavis and Clovis take a companion
Clovis Oncology to develop and commercialize hENT1 companion diagnostic with Ventana Medical Systems
Licensed to test
Licensed to test
Warnex Medical Laboratories obtains rights to establish Epigemomics’ laboratory-developed test for Septin9
